Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation

Clinical trial NCT06108414 · RECRUITING

Trial details

NCT number: NCT06108414
Sponsor: China National Center for Cardiovascular Diseases
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Anticoagulant Adverse Reaction Stroke Major Adverse Cardiac Events

Start date: 2024-09-01
Primary completion: 2026-12-31
Enrollment: 4374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.